Himension Capital (Singapore)’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Himension Capital (Singapore)'s MRNA Position: Q2 2026 in Review
Himension Capital (Singapore) reduced its Moderna (MRNA) stake by 29% in Q2 2026, selling an estimated $524K and leaving 25,218 shares worth $1.77M. The position accounts for 0.11% of the portfolio, ranked #70.
Himension Capital (Singapore) first reported a position in MRNA in Q3 2023 and has held it in 9 quarters since. The position peaked at $1.8M in Q1 2026. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Himension Capital (Singapore) held 25,218 shares of Moderna worth $1.77M as of Q2 2026.
- Himension Capital (Singapore) sold 10,120 Moderna shares in Q2 2026, an estimated $524K.
- Moderna made up 0.11% of Himension Capital (Singapore)'s portfolio in Q2 2026, its #70 holding.
- Himension Capital (Singapore) first reported a position in Moderna in Q3 2023 and has held it in 9 quarters since.
- Himension Capital (Singapore)'s Moderna position peaked at $1.8M in Q1 2026.
- 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Himension Capital (Singapore)'s 13F filing for Q2 2026, filed 13 Aug 2026.